Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
However, big pharma will still have the ability to charge premium prices for innovator molecules, especially those with higher efficacy (eg retatrutide) and those aimed at niche patient populations rather than the mass market (eg survodutide, which is targeting MASH endpoints in clinical trials)
Qsymia combines phentermine and topiramate, effectively reducing body weight in clinical trials
The negotiated unit price would apply to all forms of the drug Ozempic
ii) Utilizing the steric hindrance conferred by dimerization reduces protease access to the active site and significantly improving stability against proteases 49,50
US$ 22.70
US$ 28.35
US$ 26.01
US$ 24.76
US$ 23.74
US$ 20.52
